UBS reiterates a buy for Greenlight Capital Re….Barron’s says it looks appealing

In its latest research note yesterday, UBS reiterated to buy Greenlight Capital Re, giving it a price target of $34. [Read More]
To access this content, you must be a member. Visit the Plans page for details.